UAE’s Mubadala Healthcare contributes to UK COVID-19 diabetes drug trial
- The trial, known as Arcadia, was approved following preclinical research
- If successful, it could be prescribed by doctors for people with diabetes
Excalibur Medicines Ltd.
Arab News
